ln this report we describe a novel, nonisotopic hybridization assay for the measurement of viral RNA in biological samples. The assay involved a solution-phase reaction between a biotinylated DNA probe and RNA target sequences. Labeled hybrids were detected in an immunoreaction by using a solid-phase anti-biotin antibody and an enzyme-labeled monoclonal antibody specific for DNA-RNA hybrids. This monoclonal antibody solution hybridization assay was compared with an antigen-capture immunoassay for the detection of human immunodeficiency virus in 436 cell culture samples from 60 seropositive patients. The sensitivity and specificity of the hybridization assay were 93.5 and 94.6%, respectively. Detection of human immunodeficiency virus solely by hybridization in the initial sample but not subsequent samples from seven cultures may reflect detection of virus that was present in the patients' lymphocytes but did not replicate in vitro. Since the assay method is adapatable to the detection of either RNA or DNA, it could provide a means for the detection of a wide range of viral nucleic acids.
Nucleic acid hybridization assays have great promise as diagnostic methods in virology (20) . The vast information encoded in viral genetic sequences, the specificity of base pair interactions, and the kinetic and thermodynamic properties of the reaction between complementary polynucleotide chains make possible the construction of highly sensitive and specific assays for the detection and identification of viral nucleic acids. In addition, recent advances in recombinant DNA technology and solid-phase oligonucleotide synthesis make it feasible to produce large quantities of welldefined, stable, and inexpensive nucleic acid probes as reagents. However, currently available techniques have not been widely applied to the diagnosis of human viral infections. Limitations of these techniques include the reliance on high-energy isotopic probes, the inefficient binding of target nucleic acids to solid-energy probes, the inefficient binding of target nucleic acids to solid-phase surfaces, the prolonged incubation times required to achieve maximal sensitivity, and the inability to objectively quantify results in a practical manner.
To overcome the problems of current hybridization techniques, methods have been developed for the linkage to nucleic acids of biotin and other markers which can be measured by means of enzymatic and fluorescence detection systems (4, 5, 8, 9, 15, 17, 18) . The development of nonisotopic probes, however, solves only one of the problems associated with the application of hybridization assays for the detection of viral agents in biological samples. We have also developed assay formats in which hybridization reactions can be performed in a liquid phase environment to enhance the rate of the reactions and to minimize the interference due to extraneous material present in biological fluids. A second objective of our work has been to develop assays that generate products that can be quantified by means of simple instrumentation. In particular, we have been interested in assays that can be performed in standard 96-well microdilution plates, since instrumentation for the performance and quantitation of reactions in microdilution * Corresponding author.
plates is widely available and since clinical microbiologists and researchers are familiar with this format. In this report we describe a novel hybridization assay system which addresses many of the problems encountered with currently available techniques.
MATERIALS AND METHODS
Nucleic acid reagents. The recombinant plasmid pGEM-ARV containing a 2.9-kilobase fragment spanning nearly all of the polymerase gene and the 3' end of the gag gene of a molecular clone of the LAV strain of human immunodeficiency virus type 1 (HIV-1) was the generous gift of Howard Gendelman and Malcolm Martin of the Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases. The recombinant plasmid pCBIII21 containing a subgenomic cDNA fragment of the coxsackievirus B3 (Nancy) genome was kindly provided by Steve Tracey. The plasmids were amplified by bacterial growth, recovered by lysis of cellular pellets, and purified by CsCl-ethidium bromide density centrifugation by established methods (12) .
Traces of residual RNA in the purified plasmid preparations were degraded by alkali denaturation as follows. A 25-1tl aliquot of 0.15 M NaOH was added to 50 ,ul of a 0.5-mg/ml solution of the plasmid in 10 Biotinylation of probes. The plasmids were labeled with biotin by the sodium bisulfite-ethylenediamine method with conditions previously shown to yield the optimum biotin content for efficient hybridization of the probe to target sequences (18) . Briefly 1 M sodium bisulfite-3 M ethylenediamine adjusted to pH 6 with concentrated HCI was freshly prepared, and hydroquinone was added to a final concentration of 1 mg/ml. Since the bisulfite-catalyzed transamination of cytosine residues is single strand specific, the probe was heat denatured and cooled on ice before the reaction was EDTA was added to an equal volume of the samples. The mixtures were heated to 100°C for 3 min to denature the probe, and the hybridization reaction was performed for 3 h at 68°C in a water bath. After completion ofthe hybridization reaction, the mixtures were cooled to room temperature, and 24 pl of 10% Triton X-100 was added. The addition of Triton X-100 was necessary to form micelles containing SDS and thus prevent the high SDS concentration from desorbing antibody from the coated microdilution plates used in the next step of the assay. For the immunoreaction 100 pli of the hybridized sample was added to duplicate wells of a black polystyrene 96-well microdilution plate (microFluor 'B' U-plate; Dynatech no. 011-010-7201). Black plates were used to minimize nonspecific fluorescence. The plates were prepared by incubation overnight at 4°C with 100 pl ofgoat antibody to biotin (Sigma Chemical Co.) diluted to 1 ,ug/ml in 0.06 M carbonate buffer (pH 9.6). Before use the plates were washed five times with phosphate-buffered saline (PBS) containing 0.05% Tween 20 (PBST). The hybridized samples were incubated on the plate overnight at room temperature. After five washes with PBST, 100 pul of,-D-galactosidase-labeled Fab' fragments of a moncolonal antibody to DNA-RNA duplexes diluted to 0.065 ,ug/ml in PBST-0.5% gelatin-0.5% normal mouse serum was added to the wells. The P-D-galactosidase-labeled Fab' fragments of the monoclonal antibody to DNA-RNA hybrids was the generous gift of Robert J. Carrico, Miles Laboratories, Inc., Elkhart, Ind. The binding properties of the monoclonal antibody and the preparation of the labeled Fab' fragments have been described previously (2, 21 
RESULTS
The design of the monoclonal antibody solution hybridization assay is depicted in Fig. 1 . The assay format was based on a hybridization reaction in solution between a biotinylated DNA probe and complementary viral RNA target sequences. Labeled hybrids were then bound in an immunoreaction to the wells of a microdilution plate coated with an anti-biotin antibody. After removal of unbound nucleic acids by washing, the amount of probe-virus nucleic acid hybrids bound to the solid phase was measured by reaction with enzyme-labeled monoclonal antibody directed at DNA-RNA hybrids and the appropriate enzyme substrate. We found that this format could detect as little as 1 pg (0.05 pg per 50-.l reaction volume) of target RNA per ml with a model system composed of complementary homopolymeric nucleic acids (Fig. 2) .
We applied the monoclonal antibody solution hybridization assay for the detection of HIV RNA in cell culture samples. The optimum conditions for the assay were determined in preliminary experiments with a cell culture sample inoculated with a wild-type HIV isolate and a control sample from an uninoculated culture. Nucleic acids were extracted from lysed cells, and a solution hybridization reaction was performed for 3 h with 0.5 p.g of a biotinylated probe per ml. The incubation temperature, which was 24°C below the calculated thermal denaturation temperature (Tm) of a perfectly matched hybrid, constitutes a moderately high stringency hybridization reaction for DNA-RNA hybrids. Although the signal could be increased with higher probe concentrations and longer hybridization times, this did not alter the sensitivity of the assay for detection of HIV RNA (data not shown). Labeled hybrids formed between the biotinylated DNA probe and viral RNA sequences were detected in a sandwich immunoassay with a solid-phase goat anti-biotin antibody and ,B-D-galactosidase-labeled Fab' fragments of a monclonal antibody to DNA-RNA duplexes. The assay was capable of detecting viral RNA at a i0-' dilution of a cell culture inoculated with an HIV isolate (Fig. 3A) . The sensitivity of the assay was compared with that of a dot hybridization assay with a 32P-labeled probe. The nucleic acids from extracted cell culture samples were denatured with formaldehyde and immediately applied to a nitrocellulose filter with a 96-well manifold apparatus. Hybridization was performed with the pGEM-ARV probe labeled with 2p (specific activity, 5 x 107 cpmlug). Viral RNA could only be detected at a 10-2 dilution of a positive culture on an autoradiogram developed after 6 days (Fig. 3B) . The cell culture sample inoculated with an HIV isolate was also assayed for the presence of HIV proteins by the enzyme immunoassay for HIV antigens and by a commercial antigen-capture assay (Abbott Laboratories) (7). The limit of detection of viral antigens in both assays was a 10-3 5 dilution.
We then evaluated the performance of the monoclonal antibody solution hybridization assay to detect virus in peripheral mononuclear cells cultured from HIV-seroposi- The possibility that these results were due to false-positive hybridization reactions cannot be excluded. However, we believe that this is unlikely because none of the positive samples reacted with pCBIII21, a recombinant pBr322 plasmid containing a cDNA fragment of the coxsackievirus B3 genome. The specificity of the assay is also supported by the consistently low level of reactivity observed with a sample from a culture of a pool of peripheral mononuclear cells from several seronegative donors.
It is of note that this assay format yields objective results and can allow for the performance of quantitative control reactions. These features are important for the detection of agents, such as HIV, the diagnosis of which has serious consequences for the infected individual. Although the method that we used required the cultivation of patients' lymphocytes, preliminary analyses reveal that HIV RNA can also be detected directly in the lymphocytes of infected individuals. The sensitivity and specificity of these determinations are the subject of current investigations.
We have also adapted this format for the detection of RNA from double-stranded RNA viruses such as rotaviruses, positive-stranded RNA viruses such as picornaviruses, and negative-stranded RNA viruses such as influenza viruses (R. P. Viscidi and R. H. Yolken, Abstr. VII Int. Congr. Virol., abstr. no. R.30. 5, 1987 ). Furthermore, it is possible that this method could be adapted to the detection of nucleic acids from DNA viruses such as herpesviruses and human papillomaviruses by the use of biotin-labeled single-stranded RNA probes and the measurement of DNA-RNA hybrids by the above method. Monoclonal antibody solution hybridization assays thus have the potential of becoming widely used systems for the detection of a broad range of microbial nucleic acids in biological specimens.
